33 related articles for article (PubMed ID: 7523679)
1. Membrane protein structure determination - the next generation.
Moraes I; Evans G; Sanchez-Weatherby J; Newstead S; Stewart PD
Biochim Biophys Acta; 2014 Jan; 1838(1 Pt A):78-87. PubMed ID: 23860256
[TBL] [Abstract][Full Text] [Related]
2. Biochemical studies on the mechanism of human immunodeficiency virus type 1 reverse transcriptase resistance to 1-(beta-D-dioxolane)thymine triphosphate.
Lennerstrand J; Chu CK; Schinazi RF
Antimicrob Agents Chemother; 2007 Jun; 51(6):2078-84. PubMed ID: 17403997
[TBL] [Abstract][Full Text] [Related]
3. Structure of HIV-2 reverse transcriptase at 2.35-A resolution and the mechanism of resistance to non-nucleoside inhibitors.
Ren J; Bird LE; Chamberlain PP; Stewart-Jones GB; Stuart DI; Stammers DK
Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14410-5. PubMed ID: 12386343
[TBL] [Abstract][Full Text] [Related]
4. Crystal structures of Zidovudine- or Lamivudine-resistant human immunodeficiency virus type 1 reverse transcriptases containing mutations at codons 41, 184, and 215.
Chamberlain PP; Ren J; Nichols CE; Douglas L; Lennerstrand J; Larder BA; Stuart DI; Stammers DK
J Virol; 2002 Oct; 76(19):10015-9. PubMed ID: 12208978
[TBL] [Abstract][Full Text] [Related]
5. Conformational analysis of nevirapine, a non-nucleoside HIV-1 reverse transcriptase inhibitor, based on quantum mechanical calculations.
Hannongbua S; Prasithichokekul S; Pungpo P
J Comput Aided Mol Des; 2001 Nov; 15(11):997-1004. PubMed ID: 11989627
[TBL] [Abstract][Full Text] [Related]
6. Correlation between viral resistance to zidovudine and resistance at the reverse transcriptase level for a panel of human immunodeficiency virus type 1 mutants.
Lennerstrand J; Hertogs K; Stammers DK; Larder BA
J Virol; 2001 Aug; 75(15):7202-5. PubMed ID: 11435603
[TBL] [Abstract][Full Text] [Related]
7. Biochemical mechanism of human immunodeficiency virus type 1 reverse transcriptase resistance to stavudine.
Lennerstrand J; Stammers DK; Larder BA
Antimicrob Agents Chemother; 2001 Jul; 45(7):2144-6. PubMed ID: 11408240
[TBL] [Abstract][Full Text] [Related]
8. Hybrid Ty1/HIV-1 elements used to detect inhibitors and monitor the activity of HIV-1 reverse transcriptase.
Nissley DV; Boyer PL; Garfinkel DJ; Hughes SH; Strathern JN
Proc Natl Acad Sci U S A; 1998 Nov; 95(23):13905-10. PubMed ID: 9811899
[TBL] [Abstract][Full Text] [Related]
9. 3'-Azido-3'-deoxythymidine drug resistance mutations in HIV-1 reverse transcriptase can induce long range conformational changes.
Ren J; Esnouf RM; Hopkins AL; Jones EY; Kirby I; Keeling J; Ross CK; Larder BA; Stuart DI; Stammers DK
Proc Natl Acad Sci U S A; 1998 Aug; 95(16):9518-23. PubMed ID: 9689112
[TBL] [Abstract][Full Text] [Related]
10. Binding of RNA template to a complex of HIV-1 reverse transcriptase/primer/template.
Canard B; Sarfati R; Richardson CC
Proc Natl Acad Sci U S A; 1997 Oct; 94(21):11279-84. PubMed ID: 9326600
[TBL] [Abstract][Full Text] [Related]
11. Unique features in the structure of the complex between HIV-1 reverse transcriptase and the bis(heteroaryl)piperazine (BHAP) U-90152 explain resistance mutations for this nonnucleoside inhibitor.
Esnouf RM; Ren J; Hopkins AL; Ross CK; Jones EY; Stammers DK; Stuart DI
Proc Natl Acad Sci U S A; 1997 Apr; 94(8):3984-9. PubMed ID: 9108091
[TBL] [Abstract][Full Text] [Related]
12. High resolution structures of HIV-1 RT from four RT-inhibitor complexes.
Ren J; Esnouf R; Garman E; Somers D; Ross C; Kirby I; Keeling J; Darby G; Jones Y; Stuart D
Nat Struct Biol; 1995 Apr; 2(4):293-302. PubMed ID: 7540934
[TBL] [Abstract][Full Text] [Related]
13. Amino acid substitutions in HIV-1 reverse transcriptase with corresponding residues from HIV-2. Effect on kinetic constants and inhibition by non-nucleoside analogs.
Bacolla A; Shih CK; Rose JM; Piras G; Warren TC; Grygon CA; Ingraham RH; Cousins RC; Greenwood DJ; Richman D
J Biol Chem; 1993 Aug; 268(22):16571-7. PubMed ID: 7688367
[TBL] [Abstract][Full Text] [Related]
14. A novel, non-nucleoside inhibitor of HIV-1 reverse transcriptase.
Merluzzi VJ; Rosenthal AS
Adv Exp Med Biol; 1992; 312():89-94. PubMed ID: 1381140
[No Abstract] [Full Text] [Related]
15. Clinical experience with non-nucleoside reverse transcriptase inhibitors: L-697,661 and nevirapine.
Kilby JM; Saag MS
Adv Exp Med Biol; 1996; 394():291-8. PubMed ID: 8815693
[No Abstract] [Full Text] [Related]
16. Crystals of HIV-1 reverse transcriptase diffracting to 2.2 A resolution.
Stammers DK; Somers DO; Ross CK; Kirby I; Ray PH; Wilson JE; Norman M; Ren JS; Esnouf RM; Garman EF
J Mol Biol; 1994 Sep; 242(4):586-8. PubMed ID: 7523679
[TBL] [Abstract][Full Text] [Related]
17. The structure of unliganded reverse transcriptase from the human immunodeficiency virus type 1.
Rodgers DW; Gamblin SJ; Harris BA; Ray S; Culp JS; Hellmig B; Woolf DJ; Debouck C; Harrison SC
Proc Natl Acad Sci U S A; 1995 Feb; 92(4):1222-6. PubMed ID: 7532306
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
